Tevogen Bio Holdings Inc.
TVGN
$0.39
-$0.02-4.72%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.05% | 46.91% | -9.77% | -60.51% | 39.11% |
| Total Depreciation and Amortization | -90.65% | 175.90% | 1.84% | 1.77% | 1.70% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.74% | -55.69% | 3.71% | 125.26% | -39.95% |
| Change in Net Operating Assets | 6.83% | -246.68% | 53.30% | 34.79% | -183.58% |
| Cash from Operations | -14.42% | 3.58% | -8.54% | 19.90% | -27.57% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -100.00% | -30.00% | -- | -100.00% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 720.28% | -75.00% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -50.00% | 42.86% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 110.60% | -52.50% | 100.00% | -60.00% | 78.57% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 127.29% | -286.40% | 166.04% | -187.65% | 754.96% |